Published in Am Heart J on May 01, 2005
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54
Congenital heart disease in the general population: changing prevalence and age distribution. Circulation (2007) 5.16
Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation (2014) 3.78
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ (2008) 3.63
Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarction. CMAJ (2011) 3.15
Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation (2012) 2.96
Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials. J Am Coll Cardiol (2005) 2.75
Administrative Data Feedback for Effective Cardiac Treatment: AFFECT, a cluster randomized trial. JAMA (2005) 2.54
Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ (2009) 2.50
Association between naproxen use and protection against acute myocardial infarction. Arch Intern Med (2002) 2.45
Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J (2005) 2.31
Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures. CMAJ (2008) 2.23
The potential economic impact of restricted access to angiotensin-receptor blockers. CMAJ (2011) 2.22
Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery. Am J Cardiol (2013) 2.18
Children and adults with congenital heart disease lost to follow-up: who and when? Circulation (2009) 2.10
Statins and cancer risk. Am J Med (2008) 2.09
Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. Virology (2009) 2.07
Alternative smoking cessation aids: a meta-analysis of randomized controlled trials. Am J Med (2012) 2.06
Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol (2005) 2.03
Long-term trends in use of and expenditures for cardiovascular medications in Canada. CMAJ (2009) 2.02
Changing mortality in congenital heart disease. J Am Coll Cardiol (2010) 1.99
Traditional risk factors and a Genetic Risk Score are associated with age of first acute coronary syndrome. Heart (2014) 1.95
Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med (2012) 1.94
Atrial arrhythmias in adults with congenital heart disease. Circulation (2009) 1.94
Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med (2005) 1.91
Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial. J Am Coll Cardiol (2013) 1.86
The nested case-control study in cardiology. Am Heart J (2003) 1.84
Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Am Heart J (2006) 1.82
Sex-related differences in access to care among patients with premature acute coronary syndrome. CMAJ (2014) 1.67
Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation (2014) 1.67
Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum (2008) 1.63
Life-course socioeconomic position and incidence of coronary heart disease: the Framingham Offspring Study. Am J Epidemiol (2009) 1.57
Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study. Eur J Heart Fail (2007) 1.57
Hypertension, proteinuria, and antagonism of vascular endothelial growth factor signaling: clinical toxicity, therapeutic target, or novel biomarker? J Clin Oncol (2007) 1.56
Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction. Am J Med (2003) 1.54
Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use. Ann Intern Med (2014) 1.54
Class effects of statins in elderly patients with congestive heart failure: a population-based analysis. Am Heart J (2007) 1.53
Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation (2012) 1.53
Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction. J Rheumatol (2005) 1.52
Emergence of sex differences in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort. Circulation (2006) 1.52
Updated risk factor values and the ability of the multivariable risk score to predict coronary heart disease. Am J Epidemiol (2004) 1.52
In-hospital management of atrial fibrillation: the CHADS₂ score predicts increased cost. Can J Cardiol (2011) 1.46
Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med (2013) 1.45
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial. JAMA (2013) 1.45
Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Circulation (2013) 1.44
Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol (2005) 1.44
Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect. CMAJ (2005) 1.43
Angina with "normal" coronary arteries: sex differences in outcomes. Am Heart J (2007) 1.41
Utility of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA registry. J Invasive Cardiol (2004) 1.40
Lack of benefit for routine functional testing early after coronary artery bypass graft surgery: results from the ROSETTA-CABG Registry. J Invasive Cardiol (2006) 1.40
Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA (2012) 1.36
CCORT/CCS quality indicators for acute myocardial infarction care. Can J Cardiol (2003) 1.35
An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA. J Biol Chem (2003) 1.30
Cardiovascular outcomes after a change in prescription policy for clopidogrel. N Engl J Med (2008) 1.27
Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ (2003) 1.25
Does aggressive care following acute myocardial infarction reduce mortality? Analysis with instrumental variables to compare effectiveness in Canadian and United States patient populations. Health Serv Res (2003) 1.23
Life course socioeconomic position is associated with inflammatory markers: the Framingham Offspring Study. Soc Sci Med (2010) 1.21
Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists? J Clin Oncol (2006) 1.21
Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J (2008) 1.20
Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J (2003) 1.20
In-hospital cost of total hip arthroplasty in Canada and the United States. J Bone Joint Surg Am (2004) 1.19
Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. Am J Med (2011) 1.16
Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. J Am Coll Cardiol (2003) 1.14
Ethnicity and sex affect diabetes incidence and outcomes. Diabetes Care (2010) 1.14
Depression symptoms have a greater impact on the 1-year health-related quality of life outcomes of women post-myocardial infarction compared to men. Eur J Cardiovasc Nurs (2006) 1.14
Outcomes of acute myocardial infarction in Canada. Can J Cardiol (2003) 1.14
Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery. Nat Clin Pract Oncol (2006) 1.12
Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am J Med (2009) 1.11
Gout, allopurinol use, and heart failure outcomes. Arch Intern Med (2010) 1.10
Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series. Transplantation (2004) 1.09
The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins? Arch Intern Med (2003) 1.08
The effect of smoking on arterial stiffness. Hypertens Res (2010) 1.07
Health care resource utilization in adults with congenital heart disease. Am J Cardiol (2007) 1.06
Comparison of measures of medication persistency using a prescription drug database. Am Heart J (2007) 1.03
Hospital readmissions in children with congenital heart disease: a population-based study. Am Heart J (2008) 1.02
Planning the specialized care of adult congenital heart disease patients: from numbers to guidelines; an epidemiologic approach. Am Heart J (2008) 1.01
Evaluation of phosphatidylinositol-4-kinase IIIα as a hepatitis C virus drug target. J Virol (2012) 1.01
Daily steps are low year-round and dip lower in fall/winter: findings from a longitudinal diabetes cohort. Cardiovasc Diabetol (2010) 1.00
Sex differences in step count-blood pressure association: a preliminary study in type 2 diabetes. PLoS One (2010) 0.99
Novel vascular targeting/disrupting agents: combretastatin A4 phosphate and related compounds. Curr Oncol Rep (2005) 0.98
Systematic, genome-wide, sex-specific linkage of cardiovascular traits in French Canadians. Hypertension (2008) 0.97
Outcomes and cost of coronary artery bypass graft surgery in the United States and Canada. Arch Intern Med (2005) 0.96
Impact of restrictive prescription plans on heart failure medication use. Circ Cardiovasc Qual Outcomes (2009) 0.96
Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations. CMAJ (2011) 0.96
The use of the transition cost accounting system in health services research. Cost Eff Resour Alloc (2007) 0.95
Temporal trends in revascularization and outcomes after acute myocardial infarction among the very elderly. CMAJ (2010) 0.95
Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone. Am J Cardiol (2011) 0.94
Effect of gender on treatment, resource utilization, and outcomes in congestive heart failure in Quebec, Canada. Am J Cardiol (2005) 0.94
Walking behaviour and glycemic control in type 2 diabetes: seasonal and gender differences--study design and methods. Cardiovasc Diabetol (2007) 0.93
Geriatric congenital heart disease: burden of disease and predictors of mortality. J Am Coll Cardiol (2011) 0.92
The interpretation of systematic reviews with meta-analyses: an objective or subjective process? BMC Med Inform Decis Mak (2008) 0.91
A general factor model for the Beck Depression Inventory-II: validation in a sample of patients hospitalized with acute myocardial infarction. J Psychosom Res (2008) 0.90
Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces. Can J Cardiol (2005) 0.90
Ranking hospitals according to acute myocardial infarction mortality: should transfers be included? Med Care (2006) 0.90
Sex differences in the effectiveness of statins after myocardial infarction. CMAJ (2007) 0.90
Hospital readmissions following abdominal aortic aneurysm repair. Ann Vasc Surg (2005) 0.89